The 2025 SCTO Forum will explore the latest revisions to the ICH-GCP E6(R3) guidelines, which aim to modernise and enhance clinical trial practices globally. These updates focus on improving flexibility, efficiency, and data integrity in response to evolving trial designs and technological advancements. The speakers will provide in-depth insights into the ICH GCP E6(R3) revision, covering its rationale, public consultation feedback, and main themes emphasised by stakeholders. Major implications for clinical research in Switzerland will be presented, followed by sessions focusing on risk-based approaches, quality by design, and innovative trial designs. The event will also address new data governance requirements in clinical trials.

Please note that this event is by invitation only. The presentations of the event will be uploaded on the website after the event.